ASX - By Stock
|
MDR |
Re:
Perennial Value Managment
|
|
37337
|
1 |
619 |
3 |
03/08/17 |
03/08/17 |
ASX - By Stock
|
1
|
619
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Finally bought in
|
|
37337
|
94 |
34K |
1 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
94
|
34K
|
1
|
|
ASX - By Stock
|
MDR |
Re:
AFR article
|
|
37337
|
15 |
4.0K |
2 |
02/08/17 |
02/08/17 |
ASX - By Stock
|
15
|
4.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Adapt growth accelerates
|
|
37337
|
67 |
22K |
11 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
67
|
22K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4C - quarterly
|
|
37337
|
160 |
48K |
3 |
26/07/17 |
26/07/17 |
ASX - By Stock
|
160
|
48K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Adapt sales - $2.4m
|
|
37337
|
85 |
20K |
1 |
25/07/17 |
25/07/17 |
ASX - By Stock
|
85
|
20K
|
1
|
|
ASX - By Stock
|
MDR |
Re:
Social Media
|
|
37337
|
184 |
76K |
0 |
25/07/17 |
25/07/17 |
ASX - By Stock
|
184
|
76K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR Jun-17 Quarterly Report & 4C
|
|
37337
|
18 |
5.7K |
1 |
18/07/17 |
18/07/17 |
ASX - By Stock
|
18
|
5.7K
|
1
|
|
ASX - By Stock
|
MDR |
Re:
Social Media
|
|
37337
|
184 |
76K |
0 |
07/07/17 |
07/07/17 |
ASX - By Stock
|
184
|
76K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
52 week low / EOY Expectations
|
|
37337
|
5 |
2.0K |
0 |
24/06/17 |
24/06/17 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Share price is starting to look like a Coles commercial!
|
|
37337
|
12 |
4.9K |
0 |
23/06/17 |
23/06/17 |
ASX - By Stock
|
12
|
4.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
yawn.
|
|
37337
|
44 |
14K |
1 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
44
|
14K
|
1
|
|
ASX - By Stock
|
AVR |
Share price is starting to look like a Coles commercial!
|
|
37337
|
12 |
4.9K |
3 |
22/06/17 |
22/06/17 |
ASX - By Stock
|
12
|
4.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
CardioCel 3D - A revolution is coming.
|
|
37337
|
129 |
50K |
1 |
21/06/17 |
21/06/17 |
ASX - By Stock
|
129
|
50K
|
1
|
|
ASX - By Stock
|
SAS |
Re:
SAS new website with countdown
|
|
37337
|
3 |
2.0K |
0 |
21/06/17 |
21/06/17 |
ASX - By Stock
|
3
|
2.0K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
52 week low / EOY Expectations
|
|
37337
|
5 |
2.0K |
5 |
19/06/17 |
19/06/17 |
ASX - By Stock
|
5
|
2.0K
|
5
|
|
ASX - By Stock
|
MDR |
52 week low / EOY Expectations
|
|
37337
|
5 |
2.0K |
1 |
19/06/17 |
19/06/17 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Appoints Chief Technology Officer
|
|
37337
|
8 |
2.2K |
0 |
15/06/17 |
15/06/17 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
37337
|
1.2K |
445K |
6 |
14/06/17 |
14/06/17 |
ASX - By Stock
|
1.2K
|
445K
|
6
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Appoints Chief Technology Officer
|
|
37337
|
8 |
2.2K |
0 |
13/06/17 |
13/06/17 |
ASX - By Stock
|
8
|
2.2K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Appoints Chief Operating Officer
|
|
37337
|
58 |
23K |
0 |
09/06/17 |
09/06/17 |
ASX - By Stock
|
58
|
23K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Partners with Discount Drug Stores
|
|
37337
|
9 |
3.0K |
0 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
9
|
3.0K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Partners with US Company iHealth Labs
|
|
37337
|
26 |
6.9K |
1 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
26
|
6.9K
|
1
|
|
ASX - By Stock
|
RNX |
Re:
Broker Data
|
|
37337
|
57 |
26K |
0 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
57
|
26K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Partners with US Company iHealth Labs
|
|
37337
|
26 |
6.9K |
1 |
29/05/17 |
29/05/17 |
ASX - By Stock
|
26
|
6.9K
|
1
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Partners with US Company iHealth Labs
|
|
37337
|
26 |
6.9K |
0 |
29/05/17 |
29/05/17 |
ASX - By Stock
|
26
|
6.9K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MedAdvisor Partners with US Company iHealth Labs
|
|
37337
|
26 |
6.9K |
1 |
29/05/17 |
29/05/17 |
ASX - By Stock
|
26
|
6.9K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
"Take a Closer Look"
|
|
37337
|
1.2K |
445K |
3 |
24/05/17 |
24/05/17 |
ASX - By Stock
|
1.2K
|
445K
|
3
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR Mar-17 Quarterly Report and 4C
|
|
37337
|
38 |
9.9K |
0 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
38
|
9.9K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR Mar-17 Quarterly Report and 4C
|
|
37337
|
38 |
9.9K |
2 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
38
|
9.9K
|
2
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR Mar-17 Quarterly Report and 4C
|
|
37337
|
38 |
9.9K |
0 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
38
|
9.9K
|
0
|
|
ASX - By Stock
|
RNX |
Re:
Ann: Encouraging Results from Drilling at The Trojan Gold Project
|
|
37337
|
30 |
14K |
0 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
30
|
14K
|
0
|
|
ASX - By Stock
|
RNX |
Re:
Ann: Encouraging Results from Drilling at The Trojan Gold Project
|
|
37337
|
30 |
14K |
0 |
11/05/17 |
11/05/17 |
ASX - By Stock
|
30
|
14K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Investor Newsletter
|
|
37337
|
3 |
1.5K |
3 |
10/05/17 |
10/05/17 |
ASX - By Stock
|
3
|
1.5K
|
3
|
|
ASX - By Stock
|
MDR |
Re:
International expansion
|
|
37337
|
12 |
3.3K |
2 |
10/05/17 |
10/05/17 |
ASX - By Stock
|
12
|
3.3K
|
2
|
|
ASX - By Stock
|
MDR |
Re:
International expansion
|
|
37337
|
12 |
3.3K |
4 |
06/05/17 |
06/05/17 |
ASX - By Stock
|
12
|
3.3K
|
4
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: Medicinal Cannabis Licence Secured
|
|
37337
|
79 |
37K |
0 |
05/05/17 |
05/05/17 |
ASX - By Stock
|
79
|
37K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: MDR Mar-17 Quarterly Report and 4C
|
|
37337
|
38 |
9.9K |
3 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
38
|
9.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
37337
|
350 |
143K |
10 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
350
|
143K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
37337
|
350 |
143K |
0 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
350
|
143K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Webinar Presentation - HSV-2 Phase IIa Results
|
|
37337
|
2 |
1.3K |
0 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Admedus Releases Results of HSV-2 Phase IIa Study
|
|
37337
|
350 |
143K |
1 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
350
|
143K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Pre-login to the webinar
|
|
37337
|
20 |
4.9K |
0 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
20
|
4.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Pre-login to the webinar
|
|
37337
|
20 |
4.9K |
3 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
20
|
4.9K
|
3
|
|
ASX - By Stock
|
AVR |
Pre-login to the webinar
|
|
37337
|
20 |
4.9K |
4 |
04/05/17 |
04/05/17 |
ASX - By Stock
|
20
|
4.9K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
The Unhatched Chicken Counting Olympics
|
|
37337
|
5 |
2.9K |
4 |
03/05/17 |
03/05/17 |
ASX - By Stock
|
5
|
2.9K
|
4
|
|
ASX - By Stock
|
RNX |
Re:
Golden drill results
|
|
37337
|
55 |
15K |
10 |
03/05/17 |
03/05/17 |
ASX - By Stock
|
55
|
15K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: HSV-2 Phase IIa Results Investor Webinar
|
|
37337
|
296 |
158K |
10 |
03/05/17 |
03/05/17 |
ASX - By Stock
|
296
|
158K
|
10
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Strategic Agreement Signed with RMIT
|
|
37337
|
75 |
37K |
6 |
02/05/17 |
02/05/17 |
ASX - By Stock
|
75
|
37K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: HSV-2 Phase IIa Results Investor Webinar
|
|
37337
|
296 |
158K |
3 |
01/05/17 |
01/05/17 |
ASX - By Stock
|
296
|
158K
|
3
|
|